SB465 (2026) Compare Changes

The Bill Text indicates a new section is being inserted. This situation is not handled right now, and the new text is displayed in both the changed and unchanged versions.

Unchanged Version

Text to be removed highlighted in red.

1 New Section; Controlled Drug Act; Xylazine. Amend RSA 318-B by inserting after section 1-c the following new section:

318-B:1-d Xylazine.

Notwithstanding the provisions of RSA 318-B:1-a, relative to scheduling by rulemaking of the commissioner of the department of health and human services, xylazine shall be scheduled as a schedule III controlled drug.

2 Effective Date. This act shall take effect January 1, 2027.

Changed Version

Text to be added highlighted in green.

1 New Section; Controlled Drug Act; Xylazine. Amend RSA 318-B by inserting after section 1-c the following new section:

318-B:1-d Xylazine.

Notwithstanding the provisions of RSA 318-B:1-a, relative to scheduling by rulemaking of the commissioner of the department of health and human services, xylazine shall be scheduled as a schedule III controlled drug.

2 Effective Date. This act shall take effect January 1, 2027.